|
Post by mango on Jan 15, 2020 20:36:57 GMT -5
A1c is just a proxy. It does not assess glucose homeostasis—time in range does. Kevin Sayer got one point wrong though when he put the claim in the red box within this slide during the recent JP Morgan Healthcare Conference. We know from not only all the CGM data Afrezza Users share, but from the clinical trial STAT that indeed, it is the DELIVERY METHOD + CGM. Hey Kevin, I’m paying attention, are you?!?
|
|
|
Post by ktim on Jan 15, 2020 21:41:11 GMT -5
@seyhey
Correction... the One Drop study showed about a half point drop for Afrezza with One Drop vs One Drop alone.
|
|
|
Post by letitride on Jan 15, 2020 21:49:49 GMT -5
So you know that my name isn't Kevin Sayer ... because I started buying in 2014. Kevin might be stumped, but I've been happy that the pps has been down and allowed me to buy a LOT more shares to average down. But, that's mytakeonit I have heard rumor you are not serious. Just to let you know I do believe you live on an Island. When Mannkind makes bank my kids will be able to afford one to. Lets Go!
|
|
|
Post by mytakeonit on Jan 15, 2020 21:57:33 GMT -5
Rumor ... stupor ... I have never lied. Believe what you will, but I know and so does my niece.
But, that's mytakeonit
|
|
|
Post by agedhippie on Jan 15, 2020 22:40:37 GMT -5
A1c is just a proxy. It does not assess glucose homeostasis—time in range does. Kevin Sayer got one point wrong though when he put the claim in the red box within this slide during the recent JP Morgan Healthcare Conference. We know from not only all the CGM data Afrezza Users share, but from the clinical trial STAT that indeed, it is the DELIVERY METHOD + CGM. Hey Kevin, I’m paying attention, are you?!? I think he covered all his bases there. He used HbA1c because that is the measure that the audience is used to seeing. He covered TIR with his first claim of greater than 20% TIR just by adding a CGM. Overall it's a good slide for that reason. He doesn't get sucked into educating the audience on TIR vs. HbA1c because that's not his job so he simply throws up two metrics showing that TIR increases by 20% when you add a CGM for those interested in TIR, and that MDI + CGM outperforms pump + meter (this is significant because in trials pumps give better results than MDI) and that's his job done!
|
|
|
Post by longliner on Jan 17, 2020 8:26:11 GMT -5
I'll do my small part to drive volume this fine morning!
|
|
|
Post by kuka on Jan 21, 2020 23:08:39 GMT -5
/photo/1
|
|
|
Post by longliner on Jan 21, 2020 23:48:22 GMT -5
/photo/1 Whoaaa dude!!! You're like a bull in a China shop!!! Swing them horns baby!! Negative nellies may have the edge here.
|
|
|
Post by sportsrancho on Jan 22, 2020 8:41:41 GMT -5
We have three upgrades and no sells....$2.75. A golden cross, a cup and handle, and a Macd that's almost going straight up. Someone is letting it run and traders are jumping up board because of the technicals. IMO
|
|